EXAS vs HAIN · rev $2.76B vs rev $1.56B
EXACT Sciences Corporation (EXAS) versus The Hain Celestial Group Inc (HAIN) — a side-by-side from cached financials, not a winner call.
EXACT Sciences Corporation (EXAS) is a diagnostics & research company listed on NASDAQ.
The Hain Celestial Group Inc (HAIN) is a packaged foods company listed on US.
Latest reported EXAS revenue for 2024-12-31 was $2.76B. Net income was -$1.03B. Revenue was up 10.4% from 2023-12-31 to 2024-12-31. EXAS currently screens at market cap $20.03B.
Latest reported HAIN revenue for 2025-06-30 was $1.56B. Net income was -$530.8M. HAIN currently screens at market cap $143.5M.
EXAS currently screens at market cap $20.03B. HAIN currently screens at market cap $143.5M.
Not investment advice. Open the EXAS and HAIN stock pages for the full models.
Not investment advice.